Attention deficit hyperactivity disorder (ADHD) - methylphenidate (replaced by TA98)

Methylphenidate for the treatment of attention deficit hyperactivity disorder in children and adolescents (replaced by TA98)

Description

This guidance has been replaced by Attention deficit hyperactivity disorder (ADHD) - methylphenidate, atomoxetine and dexamfetamine (review)

Guidance documents

• No documents found

Implementing this guidance

• None available

Other information

• Background information

• This guidance is currently being reviewed